MWNA
DNLI icon

Marshall Wace North America’s Denali Therapeutics DNLI Stock Holding History

Marshall Wace North America’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$11.7M Buy
231,977
+219,062
+1,696% +$12.3M 0.05% 321
2021
Q2 		$1.01M Sell
12,915
-263,011
-95% -$16.3M ﹤0.01% 1005
2021
Q1 		$15.8M Buy
275,926
+225,720
+450% +$15.1M 0.07% 304
2020
Q4 		$4.21M Sell
50,206
-396,600
-89% -$24M 0.02% 578
2020
Q3 		$16M Sell
446,806
-394,075
-47% -$11.9M 0.1% 213
2020
Q2 		$20.3M Sell
840,881
-323,471
-28% -$7.61M 0.13% 172
2020
Q1 		$20.4M Buy
1,164,352
+766,441
+193% +$16M 0.15% 154
2019
Q4 		$6.93M Buy
+397,911
New +$6.62M 0.03% 342
2018
Q1 		– Sell
-45,333
Closed -$709K – 1490
2017
Q4 		$709K Buy
+45,333
New +$815K ﹤0.01% 1065

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return